Hollencrest Capital Management Amgen Inc Transaction History

Hollencrest Capital Management

$2.36 Billion
Q3 2024

A detailed history of Hollencrest Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Hollencrest Capital Management holds 4,142 shares of AMGN stock, worth $1.15 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,142

Previous 4,136 0.15%

Holding current value

$1.15 Million

Previous $1.29 Million 3.25%

% of portfolio

0.06%

Previous 0.06%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$309.38 - $337.38 $1,856 - $2,024	6 Added 0.15%	4,142 $1.33 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $26,848 - $30,288	105 Added 2.6%	4,136 $1.19 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $6,213 - $7,347	-29 Reduced 0.71%	4,031 $894,000
Q1 2023 May 16, 2023	BUY	$225.79 - $275.2 $186,276 - $227,040	825 Added 25.5%	4,060 $981,000
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $3,435 - $4,365	-15 Reduced 0.46%	3,235 $849,000
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $8,305 - $9,366	37 Added 1.15%	3,250 $733,000
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $35,727 - $41,634	-161 Reduced 4.77%	3,213 $800,000
Q4 2020 Jan 26, 2021	BUY	$216.38 - $257.67 $10,819 - $12,883	50 Added 1.5%	3,374 $775,000
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $22,526 - $25,051	-96 Reduced 2.81%	3,324 $844,000
Q2 2019 Jul 18, 2019	SELL	$166.7 - $195.41 $2,000 - $2,344	-12 Reduced 0.35%	3,420 $630,000
Q4 2018 May 09, 2019	SELL	$178.4 - $208.25 $23,905 - $27,905	-134 Reduced 3.76%	3,432 $668,000
Q4 2018 Jan 03, 2019	BUY	$178.4 - $208.25 $23,905 - $27,905	134 Added 3.9%	3,566 $695,000
Q3 2018 May 09, 2019	SELL	$185.29 - $208.89 $22,790 - $25,693	-123 Reduced 3.46%	3,432 $652,000
Q3 2018 Oct 04, 2018	BUY	$185.29 - $208.89 $2,964 - $3,342	16 Added 0.45%	3,555 $737,000
Q2 2018 Jul 10, 2018	SELL	$166.05 - $186.51 $65,423 - $73,484	-394 Reduced 10.02%	3,539 $0
Q1 2018 Apr 24, 2018	BUY	$169.43 - $198.0 $847 - $990	5 Added 0.13%	3,933 $671,000
Q4 2017 Jan 19, 2018	BUY	$168.79 - $188.59 $168 - $188	1 Added 0.03%	3,928 $0
Q3 2017 Oct 10, 2017	BUY	$167.29 - $191.0 $656,947 - $750,057	3,927	3,927 $732,000

Others Institutions Holding AMGN

# of Institutions

3,078

Shares Held

405M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.

Account

Hollencrest Capital Management Amgen Inc Transaction History